Meteora Capital’s Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 CPUH.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-33,849
Closed -$2K 435
2022
Q3
$2K Buy
+33,849
New +$6.57K ﹤0.01% 344

Other funds holding CPUH.WS

Meteora Capital's CPUH.WS Position: Q4 2022 in Review

Meteora Capital sold out of Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (CPUH.WS) in Q4 2022, closing a stake of 33,849 shares — an estimated $2K sold.

Meteora Capital first reported a position in CPUH.WS in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 70 funds tracked by Wall St. Rank hold CPUH.WS as of Q4 2022.

  • Meteora Capital reported no remaining Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Meteora Capital sold 33,849 Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q4 2022, an estimated $2K.
  • Meteora Capital first reported a position in Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q3 2022 and held it in 1 quarter.
  • Meteora Capital's Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $2K in Q3 2022.
  • 70 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q4 2022.

Based on Meteora Capital's 13F filing for Q4 2022, filed 14 Feb 2023.